A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

GC Biopharma (006280.KS), a leading global biopharmaceutical company, today announced the first shipment of BARYTHRAX inj., the world's first recombinant anthrax vaccine. The product, jointly ...

(GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: ...

Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...

An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...

The global market for IVD Raw Materials was valued at US$27.7 Billion in 2024 and is projected to reach US$35.8 Billion by 2030, growing at a CAGR of 4.3% from 2024 to 2030. This comprehensive report ...

Paranovus Entertainment (NASDAQ: PAVS) Goes Parabolic on Interim Results ...

According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

Norovirus is the leading cause of gastroenteritis and is responsible for hundreds of thousands of deaths every year. However, ...

Leading synthetic biologists have shared hard-won lessons from their decade-long quest to build the world's first synthetic ...

DNA nanostructures are exciting new biomedical tools with myriad potential in treatment, diagnosis and disease prevention.

Cancer isn't just about broken genes—it's about broken architecture. Imagine a city where roads suddenly vanish, cutting off ...